BNTX

#528
BioNTech SE American Depositary Share
99.69 USD
+1.30%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
98.82
100.04
Jahresspanne
79.52
123.98
Tagesänderung
+1.30%
Monatliche Änderung
+8.36%
6 month change
-4.75%
Jahresänderung
+0.78%
Vorheriger Schlusskurs
98.41
Eröffnung
98.82
Bid
Ask
Tief
98.82
High
100.04
Volumen
42
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik Dividenden
Vierteljährlich Jährlich
Gewinn- und Verlustrechnung Bilanz Cashflow
Wert Q4, 24Q4, 25 TTM

BioNTech SE - American Depositary Shares

BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases. The company utilizes technology platforms including mRNA-based therapies, targeted therapies, and immunomodulators, to develop its treatments. BioNTech's pipeline includes several late-stage programs in oncology testing combination therapy approaches to improve treatment outcomes. In the field of infectious diseases, BioNTech, partnering with Pfizer, developed Comirnaty, the first approved mRNA-based vaccine, which was widely used during the COVID-19 pandemic.

Nachrichten